B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid TumorsZongliang Zhang, Aiping Tong, Tingyue Zhou et al.|Molecular Therapy — Oncolytics|2020Cited by 142
Bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor T cells against anaplastic meningiomaXin Tang, Liangxue Zhou, Fujun Liu et al.|Clinical & Translational Immunology|2020Cited by 75
Frequent B7-H3 overexpression in craniopharyngiomaCaili Chen, Aiping Tong, Yuelong Wang et al.|Biochemical and Biophysical Research Communications|2019Cited by 22
Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacyCheng Huang, Gang Guo, Hongjian Li et al.|Theranostics|2020Cited by 22
Overexpression of B7-H3 as an opportunity for targeted therapy in head and neck cancers.Juanjuan Hu, Hui Yang, Meijun Zheng et al.|PubMed|2019Cited by 11